ReviewPLoS genetics2020
Technical and social issues influencing the adoption of preprints in the life sciences.
Review in PLoS genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- A how-to guide for code sharing in biology.PLoS biology · 2024Review
- An international, cross-sectional survey of preprint attitudes among biomedical researchers.F1000Research · 2024Article
- Article
- How many authors does it take to publish a high profile or classic paper?Molecular biology of the cell · 2022Article
- Examining linguistic shifts between preprints and publications.PLoS biology · 2022Article
- Motivations, concerns and selection biases when posting preprints: A survey of bioRxiv authors.PloS one · 2022Article
- Science in motion: A qualitative analysis of journalists' use and perception of preprints.PloS one · 2022Article
- Personal observations on COVID-19 and the conduct and application of biomedical science.Interface focus · 2021Article
- Preprinting is positively associated with early career researcher status in ecology and evolution.Ecology and evolution · 2021Article
- Adjusting the use of preprints to accommodate the 'quality' factor in response to COVID-19.Journal of Taibah University Medical Sciences · 2021Article
- Development, implementation and impact of a new preprint solicitation process atProceedings. Biological sciences · 2021Article
- Preprints and Medical Journals: Some Things You Should Know as an Author.Balkan medical journal · 2021Article
- The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscape.PLoS biology · 2021Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Preprints are gaining visibility in many fields. Thanks to the exponential growth in submissions to bioRxiv, an online server for preprints in biology, versions of manuscripts prior to the completion of journal-organized peer review are poised to become a standard component of the publishing experience in the life sciences. Here, we provide an overview of current challenges facing preprints, both technical and social, and a vision for their future development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.